Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Abeona Therapeutics Inc (ABEO) – Abeona Therapeutics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ABEO trades at $5.77, up 2.12% with a bullish technical signal supported by moving averages. The company shows exceptional profitability with 454.86% net income margin and 70.99% ROE, though revenue remains modest at $5.82M. Recent Q1 2026 earnings beat expectations, and the company is expanding its ZEVASKYN treatment network with new centers activated.
Outlook remains positive with strong analyst support (66.7% buy ratings) and attractive valuation metrics (P/E 6.07, EV/EBITDA 2.5). Key risks include negative operating cash flow and reliance on treatment center expansion for revenue growth. The stock presents opportunity for growth investors seeking biopharma exposure.
Read full analysis

Key Stats

  • Market Cap
    $327.72M
  • Sector
    Health
  • 3M Drawdown
    -14.81%
  • Enterprise Value
    $182.62M
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    18 days
$5.77
52W Low: $4.17
11 Nov 2025
52W High: $7.23
22 Aug 2025

Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $327.72M, with an enterprise value of $182.62M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -14.81%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 18 days, indicating typical investor behavior on the platform.

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $327.72M
  • Sector
    Health
  • 3M Drawdown
    -14.81%
  • Enterprise Value
    $182.62M
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    18 days
$5.77
52W Low: $4.17
11 Nov 2025
52W High: $7.23
22 Aug 2025

Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $327.72M, with an enterprise value of $182.62M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -14.81%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 18 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!